This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thomas, G. N. Articles by Critchley, J. A. J. H. Search for Related Content PubMed PubMed Citation Articles by Thomas, G. N. Articles by Critchley, J. A. J. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Obesity Related Collections Clinical genetics Obesity Other hypertension

(Hypertension. 2000;36:177.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Modulation of Blood Pressure and Obesity With the Dopamine D2 Receptor Gene TaqI Polymorphism

G. Neil Thomas; Brian Tomlinson; Julian A. J. H. Critchley

From the Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR.

Correspondence to Dr G. Neil Thomas, Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR. E-mail thomas1997{at}cuhk.edu.hk

Abstract—Pharmacological data suggest that obesity and blood pressure (BP) may be modulated through the dopamine D2 receptor (DD2R), which may represent an underlying mechanism that links these conditions. A TaqI polymorphism near the DD2R gene has been associated with indices of obesity in white populations. We compared anthropometric and fasting plasma biochemical parameters between 209 nondiabetic hypertensive and 174 gender-matched normotensive Chinese subjects. The hypertensives had increased dyslipidemia, increased fasting plasma glucose concentrations, and a greater degree of obesity. The A1 and A2 alleles of the DD2R gene TaqI polymorphism were identified with a polymerase chain reaction–based restriction fragment length polymorphism protocol. The A1 allele frequency was decreased in the hypertensives (42.0%) compared with the control subjects (52.0%, P=0.006), and genotype frequencies were different (P=0.05) between the 2 groups. In the combined population (n=383), systolic, diastolic, and mean arterial BPs were 6, 5, and 6 mm Hg lower, respectively, in subjects with the A1A1 genotype relative to the A2A2 genotype (all P<0.05), whereas skinfold thickness was increased at the iliac (P<0.001) and triceps (P<0.03) sites but not at the biceps or subscapular sites. Furthermore, this DD2R gene polymorphism was shown to be a significant independent predictor of diastolic BP and iliac and triceps skinfold thicknesses (all P<0.03). These contrasting associations of the DD2R TaqI polymorphism A1 allele with lower BP but increased markers of "gynoidal" or peripheral subcutaneous obesity (iliac and triceps skinfold thicknesses) in our Chinese population may provide some insight into the underlying relationship between BP and body fat distribution, but the exact nature of this link remains to be determined.

Key Words: body mass index • race • dopamine • receptors, dopamine • genetics • hypertension, obesity

This article has been cited by other articles:

				C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF]

				I. Armando, X. Wang, V. A. M. Villar, J. E. Jones, L. D. Asico, C. Escano, and P. A. Jose Reactive Oxygen Species-Dependent Hypertension in Dopamine D2 Receptor-Deficient Mice Hypertension, March 1, 2007; 49(3): 672 - 678. [Abstract] [Full Text] [PDF]

				K. J. Pettersson-Fernholm, C. M. Forsblom, M. Perola, J. A. Fagerudd, and P.-H. Groop Dopamine D3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1432 - 1436. [Abstract] [Full Text] [PDF]

				X. X. Li, M. Bek, L. D. Asico, Z. Yang, D. K. Grandy, D. S. Goldstein, M. Rubinstein, G. M. Eisner, and P. A. Jose Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice Hypertension, September 1, 2001; 38(3): 303 - 308. [Abstract] [Full Text] [PDF]